Masimo Corporation (MASI)
-NasdaqGS | Prev Close: | 22.19 |
|---|
| Open: | N/A |
|---|
| Bid: | 19.95 x 100 |
|---|
| Ask: | 22.97 x 500 |
|---|
| 1y Target Est: | 24.07 |
|---|
| Beta: | 0.92 |
|---|
| Next Earnings Date: | 31-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 18.20 - 25.35 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 393,503 |
|---|
| Market Cap: | 1.26B |
|---|
| P/E (ttm): | 20.55 |
|---|
| EPS (ttm): | 1.08 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Masimo CEO Joe Kiani Receives Argyros Medal for Visionary Leadership & Commitment to Patient SafetyPR Newswire(Tue, 08:04 SGT)
- New Clinical Study Finds Masimo rainbow® Acoustic Monitoring™ Technology More Accurately, Precisely, and Reliably Detects Ventilatory Pauses in Post-Surgical PatientsPR Newswire(Thu, 16 May)
- [video] Ratings Moves: CDI, IMO, MASIat TheStreet(Thu, 16 May)
- MASIMO CORP FinancialsEDGAR Online Financials(Thu, 16 May)
- Masimo announces clinical study results for company's noninvansive PVIat theflyonthewall.com(Wed, 15 May)
- New Published Clinical Study Shows Masimo PVI® Helps Clinicians Assess Fluid Responsiveness in Pediatric PatientsPR Newswire(Wed, 15 May)
- Masimo Corporation Stock Upgraded (MASI)at TheStreet(Wed, 15 May)
- Masimo Wins a Major Turkish ClientZacks(Tue, 14 May)
- New Clinical Studies Presented at the International Anesthesia Research Society Annual Meeting Show Benefits of Masimo Noninvasive Patient Monitoring Technologies: SpHb®, RRa™, and SedLine®PR Newswire(Mon, 13 May)
- MASIMO CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, 8 May)
Key Statistics
| Forward P/E (1 yr): | 18.19 |
|---|
| P/S (ttm): | 2.47 |
|---|
| Ex-Dividend Date: | 23-Nov-12 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.14 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.28 |
|---|
| Mean Recommendation*: | 2.7 |
|---|
| PEG Ratio (5 yr expected): | 1.31 |
|---|
Business Summary
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology (SET), which provides the capabilities of measure-throu...
View More